TNF and Crohn disease: TNFα antagonists have been developed for the treatment of rheumatoid arthritis (RA), psoriatic arthritis, juvenile idiopathic arthritis, ankylosing spondylitis, Crohn’s disease, and ulcerative colitis [11,12,13,14].